Yiqi Wenyang decoction protects against the development of atherosclerosis by inhibiting vascular inflammation
YQWY protects against vascular inflammation and atherosclerosis by suppressing NF-κB pathway, suggesting the potential of YQWY and its active ingredients as novel anti-atherosclerotic therapeutics.
Authors
- Zhe Huang (ORCID: https://orcid.org/0000-0002-3524-2806)
- C. Shiu
- Lingling Sun (ORCID: https://orcid.org/0000-0001-7033-1698)
- Shuang Hua (ORCID: https://orcid.org/0000-0002-7169-392X)
- Ping Gu (ORCID: https://orcid.org/0000-0002-7091-871X)
- Shujie Zhang (ORCID: https://orcid.org/0000-0002-6520-398X)
- Xingqun Yan (ORCID: https://orcid.org/0000-0002-5909-1205)
- Han Zhang (ORCID: https://orcid.org/0000-0002-1355-6492)
- Weimin Jiang
- Yao Zhu
Institutions
- Zhejiang Chinese Medical University (CN)
- Nanjing University of Chinese Medicine (CN)
- Shanghai Jiao Tong University (CN)
- Nanjing General Hospital of Nanjing Military Command (CN)
- Pudong New Area People's Hospital (CN)
- Southern Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Pharmaceutical Biology
- Published
- 2025-04-20
- DOI
- https://doi.org/10.1080/13880209.2025.2492650
- Citations
- 3
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.39
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province